Promoters influence the kinetics of transgene expression following adenovector gene delivery

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Gene Medicine

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jgm.1127PMID 18064718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway.

  2004cited by this paper
• Increased revascularization efficacy after administration of an adenovirus encoding VEGF121

  2004cited by this paper
• Molecular basis of the inflammatory response to adenovirus vectors

  2003cited by this paper
• TNFα and IFNγ Induced by Innate Anti-adenoviral Immune Responses Inhibit Adenovirus-Mediated Transgene Expression

  2001cited by this paper
• TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.

  2001cited by this paper
• Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors.

  2000cited by this paper
• Sustained Expression of Human Apolipoprotein A-I after Adenoviral Gene Transfer in C57BL/6 Mice: Role of Apolipoprotein A-I Promoter, Apolipoprotein A-I Introns, and Human Apolipoprotein E Enhancer

  2000cited by this paper
• Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells.

  2000cited by this paper
• Effective repeat administration with adenovirus vectors to the muscle

  2000cited by this paper
• Use of a Liver-Specific Promoter Reduces Immune Response to the Transgene in Adenoviral Vectors

  1999cited by this paper
• DNA from Both High-Capacity and First-Generation Adenoviral Vectors Remains Intact in Skeletal Muscle

  1999cited by this paper
• Adenoviral Gene Therapy Leads to Rapid Induction of Multiple Chemokines and Acute Neutrophil-Dependent Hepatic Injury in Vivo

  1999cited by this paper
• Implications of maturation for viral gene delivery to skeletal muscle.

  1998cited by this paper
• Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers

  1998cited by this paper
• Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver

  1997cited by this paper
• Promoter Attenuation in Gene Therapy: Interferon-γ and Tumor Necrosis Factor-α Inhibit Transgene Expression

  1997cited by this paper
• Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer

  1997cited by this paper
• Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo

  1997cited by this paper
• Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.

  1997cited by this paper
• Long-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral Vector

  1997cited by this paper
• Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.

  1996influential reference
• Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1996cited by this paper
• Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.

  1996cited by this paper
• Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors

  1996cited by this paper
• Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

  1995cited by this paper
• The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants.

  1995cited by this paper
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1995cited by this paper
• A Retroviral Vector Containing a Muscle-Specific Enhancer Drives Gene Expression Only in Differentiated Muscle Fibers

  1995cited by this paper
• Interferon-γ Inhibits Transgene Expression Driven by SV40 or CMV Promoters but Augments Expression Driven by the Mammalian MHC I Promoter

  1995cited by this paper
• Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.

  1995cited by this paper
• Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.

  1995cited by this paper
• Neural-targeted gene therapy for rodent and primate hemiparkinsonism.

  1994cited by this paper
• MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.

  1994cited by this paper
• Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.

  1992cited by this paper
• Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice

  1989cited by this paper
• Physical mapping of a large-plaque mutation of adenovirus type 2

  1979cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977influential reference

• Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector

  2024cites this paper
• Controlling timing and location in vaccines

  2020cites this paper
• Genetic Vaccine for Cancer

  2019cites this paper
• A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy

  2019cites this paper
• Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig

  2018cites this paper
• A gene therapy approach for Argininosuccinic aciduria

  2017cites this paper
• Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination

  2016cites this paper
• Adenoviral Vector Vaccines Antigen Transgene

  2016cites this paper
• Gene delivery with viral vectors for cerebrovascular diseases.

  2013cites this paper
• Optimization of hCFTR lung expression in mice using DNA nanoparticles.

  2012cites this paper
• Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors

  2012cites this paper
• Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

  2011cites this paper
• Construção e caracterização de vetor adenoviral com promotor responsivo ao seu próprio transgene p53 e sua comparação com um vetor de promoção constitutiva.

  2011cites this paper
• Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity.

  2010cites this paper
• Delivery Systems for Gene Transfer

  2010cites this paper
• CpG methylation modulates tissue-specific expression of a transgene in chickens.

  2010cites this paper
• The p1D4-hrGFP II expression vector: a tool for expressing and purifying visual pigments and other G protein-coupled receptors.

  2010cites this paper
• Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector

  2009cites this paper
• Viral vectors in malaria vaccine development

  2009cites this paper
• Persistent expression of PEDF in the eye using high-capacity adenovectors.

  2008cites this paper
• Gene transfer: the challenge of regulated gene expression.

  2008cites this paper
• A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice.

  2008cites this paper
• DNA vaccination and gene therapy: optimization and delivery for cancer therapy

  2008cites this paper